Amir A. Jazaeri, MD, on Metastatic Cervical Cancer: The Role of Immunotherapy

March 25, 2021 By The ASCO Post Staff

Amir A. Jazaeri, MD, of The University of Texas MD Anderson Cancer Center, discusses data on the safety and efficacy of adoptive cell transfer using autologous tumor-infiltrating lymphocytes (LN-145) to treat patients with recurrent, metastatic, or persistent cervical carcinoma whose tumors have progressed on prior systemic therapy (ID # 10224).

Related Content